{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T12:56:04Z","timestamp":1753880164866,"version":"3.41.2"},"reference-count":12,"publisher":"American Society for Microbiology","issue":"4","license":[{"start":{"date-parts":[[2021,3,19]],"date-time":"2021-03-19T00:00:00Z","timestamp":1616112000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["J Clin Microbiol"],"published-print":{"date-parts":[[2021,3,19]]},"abstract":"<jats:p>The U.S. Food and Drug Administration currently uses the nasopharyngeal swab specimen as the reference standard for evaluation of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) assays. We propose that the patient-infected status algorithm is a superior way to classify whether an individual is infected or not infected.<\/jats:p>","DOI":"10.1128\/jcm.00147-21","type":"journal-article","created":{"date-parts":[[2021,1,27]],"date-time":"2021-01-27T13:24:25Z","timestamp":1611753865000},"update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":1,"title":["Is the Patient Infected with SARS-CoV-2?"],"prefix":"10.1128","volume":"59","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6922-7364","authenticated-orcid":true,"given":"Jeffrey D.","family":"Klausner","sequence":"first","affiliation":[{"name":"Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3667-9719","authenticated-orcid":true,"given":"Noah","family":"Kojima","sequence":"additional","affiliation":[{"name":"UCLA School of Medicine, University of California Los Angeles, Los Angeles, California, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5372-8706","authenticated-orcid":true,"given":"Susan M.","family":"Butler-Wu","sequence":"additional","affiliation":[{"name":"Department of Pathology, Keck School of Medicine of USC, Los Angeles, California, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2018-022510"},{"key":"e_1_3_2_3_2","volume-title":"Molecular diagnostic template for commercial manufacturers","author":"Food and Drug Administration","year":"2020","unstructured":"Food and Drug Administration. 2020. Molecular diagnostic template for commercial manufacturers. Food and Drug Administration, Silver Spring, MD. https:\/\/www.fda.gov\/media\/135900\/download."},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1186\/s12916-020-01810-8"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2020.110493"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc2016359"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaa1589"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.7326\/M20-6569"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.38.6.2027-2029.2000"},{"key":"e_1_3_2_10_2","volume-title":"Draft guidance for industry and Food and Drug Administration staff; establishing the performance characteristics of in vitro diagnostic devices for Chlamydia trachomatis and\/or Neisseria gonorrhoeae: screening and diagnostic testing; availability","author":"Food and Drug Administration","year":"2011","unstructured":"Food and Drug Administration. 2011. Draft guidance for industry and Food and Drug Administration staff; establishing the performance characteristics of in vitro diagnostic devices for Chlamydia trachomatis and\/or Neisseria gonorrhoeae: screening and diagnostic testing; availability. Food and Drug Administration, Silver Spring, MD. https:\/\/www.federalregister.gov\/documents\/2011\/05\/11\/2011-11532\/draft-guidance-for-industry-and-food-and-drug-administration-staff-establishing-the-performance."},{"key":"e_1_3_2_11_2","volume-title":"Nucleic acid amplification assays for the detection of Trichomonas vaginalis\u2014class II special controls guideline for industry and Food and Drug Administration staff","author":"Food and Drug Administration","year":"2015","unstructured":"Food and Drug Administration. 2015. Nucleic acid amplification assays for the detection of Trichomonas vaginalis\u2014class II special controls guideline for industry and Food and Drug Administration staff. Food and Drug Administration, Silver Spring, MD. https:\/\/www.fda.gov\/medical-devices\/guidance-documents-medical-devices-and-radiation-emitting-products\/nucleic-acid-amplification-assays-detection-trichomonas-vaginalis-class-ii-special-controls."},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciz1105"},{"key":"e_1_3_2_13_2","volume-title":"FDA clears first diagnostic tests for extragenital testing for chlamydia and gonorrhea","author":"Food and Drug Administration","year":"2019","unstructured":"Food and Drug Administration. 2019. FDA clears first diagnostic tests for extragenital testing for chlamydia and gonorrhea. Food and Drug Administration, Silver Spring, MD. https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-clears-first-diagnostic-tests-extragenital-testing-chlamydia-and-gonorrhea."}],"container-title":["Journal of Clinical Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/JCM.00147-21","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/JCM.00147-21","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,5]],"date-time":"2022-03-05T13:08:54Z","timestamp":1646485734000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/JCM.00147-21"}},"subtitle":[],"editor":[{"given":"Alexander J.","family":"McAdam","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2021,3,19]]},"references-count":12,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,3,19]]}},"alternative-id":["10.1128\/JCM.00147-21"],"URL":"https:\/\/doi.org\/10.1128\/jcm.00147-21","relation":{},"ISSN":["0095-1137","1098-660X"],"issn-type":[{"type":"print","value":"0095-1137"},{"type":"electronic","value":"1098-660X"}],"subject":[],"published":{"date-parts":[[2021,3,19]]},"assertion":[{"value":"2021-03-19","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e00147-21"}}